New Delhi, Feb. 4 -- The US Food and Drug Administration has greenlit clinical trails for organ transplants from genetically modified pigs. The study led by United Therapeutics Corp will begin with six patients facing end-stage renal disease - eventually being expanded to include 50 kidney failure patients. The first transplant is expected to occur in mid-2025.

According to a statement released by the company on Monday, patients will receive a UKidney transplant followed by a 24-week post-transplant follow-up period. Participants will continue to be followed for the rest of their lives - including for survival, UKidney function, and monitoring for zoonotic infections4 - during this time.

The first cohort will comprise of six transplants...